P

Inventor

LAZARUS ROBERT A

US34 patents
⚠️ This page may combine multiple inventors who share the name “LAZARUS ROBERT A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GENENTECH INC

27 patents
US5786328AJul 28, 1998

Use of kunitz type plasma kallikrein inhibitors

GENENTECH INC149 citations98
US5780265AJul 14, 1998

Kunitz type plasma kallikrein inhibitors

GENENTECH INC125 citations98
US5874407AFeb 23, 1999

Factor VIIA inhibitors

GENENTECH INC113 citations97
US5880256AMar 9, 1999

Factor VIIa inhibitors from Kunitz domain proteins

GENENTECH INC75 citations96
US5863893AJan 26, 1999

Factor VIIa inhibitors from kunitz domain proteins

GENENTECH INC66 citations96
US5834244ANov 10, 1998

Factor VIIa inhibitors from Kunitz domain proteins

GENENTECH INC82 citations96
US5795954AAug 18, 1998

Factor VIIa inhibitors from Kunitz domain proteins

GENENTECH INC81 citations96
US5736364AApr 7, 1998

Factor viia inhibitors

GENENTECH INC47 citations96
US6113896ASep 5, 2000

Pharmaceutical compositions containing ecotin and homologs thereof

GENENTECH INC80 citations95
US5843895ADec 1, 1998

Pharmaceutical administration of ecotin homologs

GENENTECH INC64 citations95
US5719041AFeb 17, 1998

DNA encoding ecotin homologs

GENENTECH INC67 citations95
US6391607B1May 21, 2002

Human DNase I hyperactive variants

GENENTECH INC74 citations94
US5032514AJul 16, 1991

Metabolic pathway engineering to increase production of ascorbic acid intermediates

GENENTECH INC76 citations93
US4757012AJul 12, 1988

Ascorbic acid intermediates and process enzymes

GENENTECH INC48 citations92
US7407785B2Aug 5, 2008

Human DNase I hyperactive variants

GENENTECH INC34 citations90
US7084109B2Aug 1, 2006

FVIIa antagonists

GENENTECH INC27 citations89
US6348343B2Feb 19, 2002

Human DNase I variants

GENENTECH INC48 citations89
US5227469AJul 13, 1993

Platelet aggregation inhibitors from the leech

GENENTECH INC33 citations87
US9453079B2Sep 27, 2016

Methods and compositions for neural disease immunotherapy

GENENTECH INC9 citations83
US7737115B2Jun 15, 2010

HGF beta chain variants

GENENTECH INC3 citations62
US9624269B2Apr 18, 2017

Peptide inhibitors of BACE1

GENENTECH INC0 citations52
US9193766B2Nov 24, 2015

Peptide inhibitors of BACE1

GENENTECH INC1 citations52
US9879094B2Jan 30, 2018

Nucleic acid molecules encoding for BACE1 antibodies

GENENTECH INC0 citations51
US10562946B2Feb 18, 2020

Chagasin-based scaffold compositions, methods, and uses

GENENTECH INC0 citations50
US7164002B2Jan 16, 2007

FVIIa antagonists

GENENTECH INC0 citations50
US10005848B2Jun 26, 2018

Method of reducing blood glucose by administering RON agonists

GENENTECH INC0 citations45
US8623821B2Jan 7, 2014

Zymogen activators

GENENTECH INC0 citations44

UNIV RUTGERS

4 patents

ATWAL JASVINDER

1 patent

KIRCHHOFER DANIEL K

1 patent

BOSANAC IVAN

1 patent